862730-04-9Relevant articles and documents
Substituted aromatic fused ring derivative, composition containing same and application
-
Paragraph 0458-0462, (2021/03/30)
The invention provides a substituted aromatic fused ring derivative, a composition containing the compound and application. The substituted aromatic fused ring derivative is a compound shown in a formula (I) or a tautomer, a stereoisomer, a prodrug, a cry
SUBSTITUTED PYRAZOLO[3,4-d]PYRIMIDINE COMPOUNDS AS RET KINASE INHIBITORS
-
Paragraph 00612; 00615, (2019/08/08)
Provided herein are compounds of the Formula I: and tautomers and pharmaceutically acceptable salts and solvates thereof, wherein R1 and R2 have the meanings given in the specification, which are inhibitors of RET kinase and are useful in the treatment and prevention of diseases which can be treated with a RET kinase inhibitor, including RET-associated diseases and disorders.
PYRAZOLOPYRIMIDINE DERIVATIVES AS BTK INHIBITORS FOR THE TREATMENT OF CANCER
-
Paragraph 00221; 00475; 00476, (2017/05/02)
This invention relates to novel compounds. The compounds of the invention are tyrosine kinase inhibitors. Specifically, the compounds of the invention are useful as inhibitors of Bruton's tyrosine kinase (BTK). The invention also contemplates the use of t